NM
Narayanasamy Mahesh
About Narayanasamy Mahesh
Data last updated:
Narayanasamy Mahesh is a Director at Glomedisys Pharmaceuticals Private Limited (since 2015). The companies operate in Trading and Financial Services. Glomedisys Pharmaceuticals Private Limited reported revenue of ₹45.2 Lakh (FY 2025). Earlier, Narayanasamy Mahesh was a Director at A1a2 Investments And Financial Consultancy Private Limited (2020–2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 12 Jan 2015 | 2015 | ₹45.2 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 22 Aug 2020 | 2019 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Narayanasamy Mahesh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Deen Alexander Vincent | 07024500 | Glomedisys Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Narayanasamy Mahesh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Narayanasamy Mahesh
Narayanasamy Mahesh currently holds 1 directorship: Glomedisys Pharmaceuticals Private Limited (Director, since 12 Jan 2015, revenue βΉ45.2 Lakh (FY 2025)).
Narayanasamy Mahesh was first appointed on 12 Jan 2015 as Director at Glomedisys Pharmaceuticals Private Limited. The most recent appointment on record is 22 Aug 2020 at A1a2 Investments And Financial Consultancy Private Limited.
Narayanasamy Mahesh held 1 earlier board appointment: A1a2 Investments And Financial Consultancy Private Limited (Director, 22 Aug 2020 to 13 Mar 2024).
The current boards of Narayanasamy Mahesh's companies include Deen Alexander Vincent (Glomedisys Pharmaceuticals Private Limited).